Top Markets
#1 Wrapped One Wrapped One +14,737.38%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +2,972.21%
#3 Black Phoenix Black Phoenix +335.54%
#4 aPriori aPriori +175.89%
#5 Bedrock Bedrock +77.61%
#6 Cysic Cysic +53.64%
#7 Prom Prom +47.31%
#8 Playnance Playnance +34.87%
#9 Bitway Bitway +28.74%
#10 COTI COTI +27.09%
Coin of the day
Wrapped One Wrapped One
Ayarlar
Dil
TüRKçE
Para birimi
USD
Tema
Pharnext S.A. Pharnext S.A.

Pharnext S.A.

ALPHA
Hisse Senetlerindeki Sıralama #42432
Based in France, Pharnext SA is a clinical-stage biopharmaceutical firm... Based in France, Pharnext SA is a clinical-stage biopharmaceutical firm dedicated to creating treatments for a range of neurodegenerative disorders, encompassing both rare (orphan) and common forms. Its pipeline features SYNGILITY, which has advanced through Phase III trials for Charcot-Marie-Tooth disease type 1A (CMT1A). Additionally, PXT864 has concluded Phase II clinical studies for Alzheimer's disease, and is also being explored for its potential in Parkinson's disease and amyotrophic lateral sclerosis (ALS). Pharnext also innovates with PLEOTHERAPY, a proprietary platform that harnesses big genetic data and artificial intelligence. In a collaborative effort, the company holds an agreement with the University Hospital Institute Mediterranee Infection to assess existing pharmaceuticals for their potential application against the COVID-19 virus. The organization was established in 2007, with its main offices located in Issy-Les-Moulineaux, France.
Hisse Fiyatı
$0.00023723
Son senkronizasyon: 2024-08-26
Piyasa Değeri
$1.41K
Değişim (1 gün)
111.67%
Değişim (1 yıl)
0.00%
Ülke
FR
Ticaret Pharnext S.A. (ALPHA)

Kategori

Healthcare
Pharnext S.A. (ALPHA) için kazanç
Dec 2023 itibarıyla kazanç TTM: $-31.69M
Pharnext S.A. şirketinin en son finansal raporlarına göre, mevcut kazancı $-31.69M'dir. 2022 yılında şirket $-43.29M kazanç elde etti, bu 2021 yılındaki $-38.48M kazanca göre önceki yıla göre azalma. Bu sayfada gösterilen kazanç, faiz ve vergiler öncesi kazançtır; yani EBIT.
Pharnext S.A. için kazanç geçmişi 2013 - 2026
Her yılın sonundaki kazanç
Yıl Kazanç Değiştir
2026 (TTM) $-31.69M 1.28%
2023 $-31.29M -27.73%
2022 $-43.29M 12.50%
2021 $-38.48M 30.75%
2020 $-29.43M -0.92%
2019 $-29.70M 21.26%
2018 $-24.50M -15.52%
2017 $-29.00M 29.32%
2016 $-22.42M 87.83%
2015 $-11.94M -8.06%
2014 $-12.98M 1.29%
2013 $-12.82M 0.00%
Benzer şirketler veya rakipler için kazanç
Şirket Kazanç Kazanç Farkı Ülke
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -16,747.05%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -6,256.06%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -9,585.74%
BE
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR